Keyphrases
Acute Lymphoblastic Leukemia
93%
Childhood Acute Lymphoblastic Leukemia
89%
L-asparaginase
38%
6-mercaptopurine (6-MP)
31%
Asparaginase-associated Pancreatitis
30%
Pediatric Hematology
25%
Pediatric Oncology
25%
Pancreatitis
20%
Maintenance Therapy
19%
Osteonecrosis
18%
Leukemia Therapy
16%
Older Adults
13%
Thromboembolism
13%
Confidence Interval
13%
High-dose Methotrexate (HD-MTX)
12%
Thiopurine Methyltransferase
12%
Mercaptopurine
11%
Pegylated Asparaginase
11%
Risk Factors
10%
Relapse Risk
10%
Induction Treatment
10%
Methotrexate
10%
Cerebrospinal Fluid
10%
Thrombosis
10%
Pegaspargase
9%
Leukemic Blast
9%
Hazard Ratio
8%
Randomized Controlled Trial
8%
Healthcare Professionals
7%
Working Diagnosis
7%
6-Thioguanine (6-TG)
7%
Childhood Leukemia
7%
Minimal Residual Disease
7%
Infections in children
6%
Ponte
6%
Odds Ratio
6%
Survivors
6%
Consolidation Treatment
6%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
6%
Hypertriglyceridemia
6%
Chemotherapy
6%
Children with Cancer
6%
Acute Pancreatitis
6%
Oncology Studies
5%
Bloodstream Infection
5%
Fish Oil
5%
Methyltransferase Activity
5%
Leukemia
5%
Flow Cytometric
5%
Pharmacokinetics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Asparaginase
43%
Mercaptopurine
34%
Methotrexate
22%
Pancreatitis
19%
Tioguanine
13%
Thromboembolism
12%
Chemotherapy
9%
Thiopurine Methyltransferase
8%
Polyethylene Glycol
7%
Remission
7%
Minimal Residual Disease
7%
Bone Necrosis
7%
Bone Marrow Toxicity
6%
Thrombosis
6%
Bloodstream Infection
5%
Pharmacokinetics
5%
Lymphatic Leukemia
5%
Hepatotoxicity
5%
Randomized Controlled Trial
5%
Hyperlipidemia
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
96%
Asparaginase
36%
Pancreatitis
33%
Pediatric Oncology
16%
Pediatric Hematology
16%
Mercaptopurine
13%
Bone Necrosis
12%
Methotrexate
9%
Malignant Neoplasm
9%
Adolescent
9%
Randomized Controlled Trial
7%
Cerebrospinal Fluid
7%
Drug Megadose
7%
Thromboembolism
7%
Systematic Review
6%
Pediatrics
6%
Leukemia
6%
Bloodstream Infection
5%
Lymphoid Leukemia
5%
Hazard Ratio
5%
